NYSEArca - Delayed Quote USD

VanEck Oil Services ETF (OIH)

325.08 -1.81 (-0.55%)
At close: April 24 at 4:00 PM EDT
325.01 -0.07 (-0.02%)
After hours: April 24 at 6:59 PM EDT
Loading Chart for OIH
DELL
  • Previous Close 326.89
  • Open 325.21
  • Bid --
  • Ask --
  • Day's Range 321.80 - 328.21
  • 52 Week Range 246.04 - 364.08
  • Volume 339,332
  • Avg. Volume 392,379
  • Net Assets 2.22B
  • NAV 326.73
  • PE Ratio (TTM) 19.99
  • Yield 1.25%
  • YTD Daily Total Return 5.61%
  • Beta (5Y Monthly) 0.98
  • Expense Ratio (net) 0.35%

The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the oil services segment. Such companies may include small- and medium-capitalization companies and foreign companies that are listed on a U.S. exchange. The fund is non-diversified.

VanEck

Fund Family

Equity Energy

Fund Category

2.22B

Net Assets

2011-12-20

Inception Date

Performance Overview: OIH

Trailing returns as of 4/23/2024. Category is Equity Energy.

YTD Return

OIH
5.61%
Category
8.79%
 

1-Year Return

OIH
19.28%
Category
16.02%
 

3-Year Return

OIH
24.29%
Category
22.08%
 

People Also Watch

Holdings: OIH

Top 10 Holdings (72.94% of Total Assets)

SymbolCompany% Assets
SLB
Schlumberger Limited 19.80%
HAL
Halliburton Company 10.85%
BKR
Baker Hughes Company 9.14%
WFRD
Weatherford International plc 4.95%
RIG
Transocean Ltd. 4.80%
TS
Tenaris S.A. 4.75%
FTI
TechnipFMC plc 4.73%
VAL
Valaris Limited 4.67%
CHX
ChampionX Corporation 4.67%
NOV
NOV Inc. 4.60%

Sector Weightings

SectorOIH
Energy   98.98%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Healthcare   0.00%

Related ETF News

Research Reports: OIH

  • Analyst Report: Biogen Inc.

    Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva are marketed via a collaboration with Roche. Biogen also markets novel multiple sclerosis drugs Plegridy, Tysabri, Tecfidera, and Vumerity. In Japan, Biogen's MS portfolio is copromoted by Eisai. Hemophilia therapies Eloctate and Alprolix (partnered with Sobi) were spun off as part of Bioverativ in 2017. Biogen's newer products include Spinraza (SMA, with partner Ionis), Leqembi (Alzheimers, with partner Eisai), Skyclarys (Friedreich's Ataxia, Reata), Zurzuvae (post-partum depression, Sage), and Qalsody (ALS, Ionis). Biogen has several drug candidates in phase 3 trials in neurology-related fields.

    Rating
    Price Target
     
  • Analyst Report: Airbnb, Inc.

    Started in 2008, Airbnb is the world’s largest online alternative accommodation travel agency, also offering booking services for boutique hotels and experiences. Airbnb’s platform offered over 7 million active accommodation listings as of Sept. 30, 2023. Listings from the company’s over 4 million hosts are spread over almost every country in the world. In the fourth quarter of 2022, 47% of revenue was from the North American region. Transaction fees for online bookings account for all its revenue.

    Rating
    Price Target
     
  • Analyst Report: Meta Platforms, Inc.

    Meta is the world’s largest online social network, with nearly 4 billion family of apps monthly active users. Users engage with each other in different ways, exchanging messages and sharing news events, photos, and videos. The firm’s ecosystem consists mainly of the Facebook app, Instagram, Messenger, WhatsApp, and many features surrounding these products. Users can access Facebook on mobile devices and desktops. Advertising revenue represents more than 90% of the firm’s total revenue, with more than 45% coming from the U.S. and Canada and over 20% from Europe.

    Rating
    Price Target
     
  • Analyst Report: Advanced Micro Devices, Inc.

    Advanced Micro Devices designs a variety of digital semiconductors for markets such as PCs, gaming consoles, data centers, industrial, and automotive applications, among others. AMD’s traditional strength was in central processing units, CPUs, and graphics processing units, or GPUs, used in PCs and data centers. Additionally, the firm supplies the chips found in prominent game consoles such as the Sony PlayStation and Microsoft Xbox. In 2022, the firm acquired field-programmable gate array, or FPGA, leader Xilinx to diversify its business and augment its opportunities in key end markets such as the data center and automotive.

    Rating
    Price Target
     

Related Tickers